Paul Morley

Paul Morley

Professor (VLCS – VERO), Director of Food Animal Research, & Sally Rau McIntosh Endowed Chair Department of Large Animal Clinical Sciences
Contact
TAMU Mailstop: 4475

Research and Scholarly Interests

  • Investigating the ecology of antimicrobial resistance in animals and food production systems
  • Using analytical epidemiology to improve our understanding of diseases in animals and people
  • Improving infection control and biosecurity to manage health risks that are important in veterinary medicine, agriculture, and public health

Education

  • PhD, University of Saskatchewan, 1995
  • DVM, Washington State University, 1989
  • BS, Veterinary Sciences, Washington State University, 1987
  • BS, Animal Sciences, Washington State University, 1986

Credentials

  • Diplomate of the American College of Veterinary Internal Medicine (DACVIM)

Short Biography

Dr. Paul Morley is a professor and director of food animal research for #TeamVERO through the Department of Large Animal Clinical Sciences (VLCS) in the CVMBS. He is an epidemiologist and veterinary internal medicine specialist who studies infectious diseases affecting people and animals. Major emphases for his professional activities include investigating the ecology of antimicrobial resistance in animals and food production systems, using analytical epidemiology to improve our understanding of diseases in animals and people, and improving infection control and biosecurity to manage health risks that are important in veterinary medicine, agriculture, and public health. His research has used shotgun metagenomics to investigate the influence of production practices in intensive agriculture systems on antimicrobial resistance and microbial ecology as these affect human, animal, and ecosystem health.

  • Antimicrobial resistance
  • Analytical epidemiology
  • Infection control
  • Biosecurity
  • Public health

Examples of Dr. Morley's research activities include:

  • Investigation of zoonotic pathogens (such as Salmonella and E. coli O157) in cattle and horses
  • Antimicrobial drug use and antimicrobial resistance in cattle and hospitalized animals
  • Control of nosocomial infections in veterinary hospitals all of which impact the human-animal interface